Xian Ping Lu
Directeur Général chez SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Fortune : 67 M $ au 30/04/2024
Postes actifs de Xian Ping Lu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Directeur Général | 24/03/2018 | - |
| Président | 24/03/2018 | - | |
| Fondateur | 21/03/2001 | - | |
| Directeur/Membre du Conseil | 21/03/2001 | 24/03/2018 | |
| Directeur Technique/Scientifique/R&D | 21/03/2001 | 01/01/2020 | |
| President | 21/03/2001 | 24/03/2018 |
Historique de carrière de Xian Ping Lu
Anciens postes connus de Xian Ping Lu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Fondateur | - | - |
Formation de Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 2 |
| France | 2 |
Opérationnelle
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
- Bourse
- Insiders
- Xian Ping Lu
- Expérience
